If not, please take a few moments to fill out the form below. It’s free, and ensures that you receive regular alerts to the latest clinical news and other content.

Email*

Password*

Keep me logged in Forgot your password?

Email*

Comparison of Caffeine Reduction and Anticholinergic Medications for Treatment of Overactive Bladder

March 23, 2009

More Overactive Bladder Clinical Trials

Painless Laser Therapy for Overactive Bladder (PLTOAB)
A Study to Investigate How Effective and Safe Solifenacin Liquid Suspension is in Treating Children/Adolescents Aged 5 to Less Than 18 Years With Symptoms of Overactive Bladder (OAB) Compared to a Non-active Drug (LION)
Study of Overactive Bladder in Women With Prolapse (SOAP)
Efficacy of Sanctura XR (Trospium Chloride) for Reducing Overactive Bladder Symptoms in Female Subjects Refractory to Detrol LA (Tolterodine Tartrate Extended Release) Daily
Single Dose Study to Measure Blood Levels and Safety of a Drug for Children With Overactive Bladder

Comparison of Caffeine Reduction and Anticholinergic Medications for Treatment of Overactive Bladder

Sponsor
IWK Health Centre

Contact
Cora A Fanning, BN, RN
P: (902)470-7158
E-mail: cora.fanning@iwk.nshealth.ca

Principal Investigator
Kimberly Trites, MD, FRCSC
IWK Health Centre

ClinicalTrials.gov Identifier
NCT00780832